Objectives: The aims of this study were to analyse the presence of oqxA and oqxB genes in a collection of extended-spectrum b-lactamase (ESBL)-producing Klebsiella pneumoniae strains, to determine their chromosomal and/or plasmidic locations and to analyse expression levels in relation to susceptibility or resistance to quinolones.
Introduction
Plasmid-borne genes conferring quinolone resistance are increasingly being recognized. 1 -3 Some years ago, the plasmid-encoded efflux pump, OqxAB, conferring resistance to quinoxaline-di-N-oxide olaquindox and used as a promoter of growth in pigs, was discovered in Escherichia coli isolates of porcine origin in Denmark and Sweden. 4 -6 OqxAB is encoded by the oqxA and oqxB genes, located on a 52 kb conjugative plasmid, designated pOLA52, and confers resistance to multiple agents, including fluoroquinolones such as nalidixic acid, ciprofloxacin and norfloxacin, as well as biocides such as triclosan and chlorhexidine. 4, 7 Recently, for the first time in a human clinical isolate, the genes for the multidrug efflux pump OqxAB were found on a plasmid in E. coli-in which IS26-like sequences flanked the plasmid-mediated oqxAB genes, suggesting that they had been mobilized as part of a composite transposon-as well as on the chromosome of Klebsiella pneumoniae. 8 The aims of this study were: (i) to analyse the presence of oqxA and oqxB genes in a collection of extended-spectrum b-lactamase (ESBL)-producing K. pneumoniae strains; (ii) to determine their chromosomal and/or plasmidic location; and (iii) to analyse their expression levels relative to susceptibility or resistance to quinolones.
Materials and methods

Bacterial strains
A multicentre collection of 114 ESBL-producing K. pneumoniae isolates recovered from urine, wounds, blood cultures, respiratory tract and other samples was analysed. Clinical and epidemiological data were reported previously.
9 -11 K. pneumoniae ATCC 27799 and K. pneumoniae ATCC 700603 were included as reference strains.
Antimicrobial susceptibility testing
Antimicrobial susceptibility was determined by microdilution and disc diffusion, following CLSI recommendations. 12 The antimicrobials tested were ciprofloxacin (Bayer, Leverkusen, Germany), moxifloxacin (Bayer), levofloxacin (Roussel Uclaf, Paris, France), norfloxacin (Sigma, Madrid, Spain), chloramphenicol (Oxoid, Madrid, Spain) and trimethoprim (Sigma). The following biocides were also tested, following CLSI guidelines: 40 g/L sodium hypochlorite (domestic bleach), 20% chlorhexidine digluconate (Sigma-Aldrich, Spain) and 50% benzalkonium chloride (Sigma-Aldrich, Denmark).
Screening for oqxA and oqxB genes
The oqxA and oqxB genes were screened using a PCR-based technique. The presence of oqxA and oqxB was detected using primers oqxAF (5 ′ -CTCGGCGCGATGATGCT-3 ′ ) and oqxAR (5 ′ -CCACTCTTCACGGGAGAC GA-3 ′ ), with products of 392 bp, and oqxBs (5 ′ -TTCTCCCCCGGCGGGA AGTAC-3 ′ ) and oqxBa2 (5 ′ -CTCGGCCATTTTGGCGCGTA-3 ′ ), with products of 512 bp, as described previously. 8 The amplicons obtained were confirmed by sequencing both chains.
Additionally, the association of IS26 with oqxA, as reported previously, 7, 8 was investigated by PCR. The presence of IS26 was performed using primers IS26a (5 ′ -TTACATTTCAAAAACTCTGCTTACC-3 ′ ) and IS26b (5 ′ -ATGAACCCATTCAAAGGCCG-3 ′ ), producing a fragment of 704 bp. 13 The association of IS26 with oqxA was determined using primers IS26-F (5 ′ -GCTGTTACGACGGGAGGAG-3 ′ ) 14 and oqxAR.
Plasmid analysis and Southern hybridization
Plasmid size was determined by Kieser extraction 15 and electrophoresis using a 0.7% agarose gel. E. coli 50192 harbouring 154, 66, 48 and 7 kb plasmids was used as a reference strain. Incompatibility groups were characterized as described previously by Caratolli et al. 16 Purified plasmids were run on a 0.7% agarose gel and transferred to a positively charged nylon membrane (Amersham Hybond-N+). Membrane hybridization was performed using PCR-amplified oqxA and oqxB genes as probes.
Analysis of mutations in the quinolone resistancedetermining region (QRDR)
Mutations of gyrA and parC genes in the QRDR were analysed by PCR and sequenced for all isolates included in the RT-PCR assays (see below), as described previously. 17 
Conjugation and transformation assays
Conjugation experiments were carried out in Luria-Bertani (LB) broth with sodium azide-resistant E. coli J53 as the recipient. Transconjugants were selected by plating onto LB agar plates containing sodium azide at 150 mg/L and ciprofloxacin at 0.05 mg/L for selection of plasmidmediated fluoroquinolone resistance.
In all cases, plasmids were not transferable by conjugation and a transformation assay was performed. Plasmids extracted by the Kieser method were electroporated into E. coli DH10B and K. pneumoniae ATCC 27799 and plated onto LB agar containing ciprofloxacin at 0.05 and 0.2 mg/L, respectively.
Semi-quantitative real-time RT-PCR
To detect oqxA gene expression, RT-PCR was carried out using a set of 24 K. pneumoniae clinical strains, whose oqxA and oqxB genes were only encoded chromosomally. K. pneumoniae ATCC 27799 and K. pneumoniae 700603 were included as references. The LightCycler Fast Start DNA Master SYBR-Green I Kit (Roche) was used for amplification. Normalized expression levels of the target gene transcripts were calculated relative to rpoB, using the 2 2DDCT method. 18 The primers used for gene amplification were OqxA-Fw-RT (5 ′ -GTAACCTGGTCACCGCGGGC-3 ′ ) and OqxA-Rw-RT (5 ′ -TGCCCTGGTGGGGGTAACCC-3 ′ ), which amplified an internal product of 207 bp.
Time -kill experiments
Time-kill kinetic assays were conducted on Mueller-Hinton broth at drug concentrations of 1× MIC, 4× MIC and 1 mg/L ciprofloxacin. Antimicrobial agent-free broth was evaluated in parallel as a control. Cultures were incubated at 378C with shaking. Viable counts were determined by serial dilution at 0, 2, 4, 6, 8 and 24 h after adding the drug and plating 100 mL of control, test culture or dilutions at the indicated times onto Mueller-Hinton agar plates. Plates were incubated for 24 h and, after the colonies were counted, the log 10 of viable cells (cfu/mL) was determined. The time needed to achieve a 3 log 10 drop in bacterial viability was also determined as an index of bactericidal activity.
Analysis of outer membrane proteins (OMPs)
OMPs were studied by SDS-PAGE using 10% polyacrylamide gels. 19 
Statistical methods
The Student's t-test for paired samples was used for analysis. A P value of ,0.05 was considered statistically significant.
Results and discussion
PCR was used to screen a total of 114 ESBL-producing K. pneumoniae clinical isolates for oqxA and oqxB genes. Strains positive for both oqxA and oqxB genes were confirmed by sequencing of the PCR products. Eighty-seven (76.3%) and 85 (74.6%) of 114 K. pneumoniae isolates were provisionally classified as positive for oqxA and oqxB, respectively. All the strains used in this study were clonally unrelated as determined by both repetitive element palindromic ('REP')-PCR and PFGE (data not shown). 9 Ten amplicons of each gene were sequenced and a BLAST search of nucleotide sequence similarity of the oqxA and oqxB PCR products gave more than 97% identity with pOLA52 (GenBank accession number EU370913) and 100% amino acid identity. There was also 100% amino acid identity of OqxA and OqxB proteins with K. pneumoniae MGH 78578 (GenBank accession number NC009648), showing a high degree of conservation for these genes. The data support the idea that oqxAB genes seem to be conserved chromosomal genes in K. pneumoniae. 7, 8, 20 In spite of this, we tested the chromosomal or plasmidic location of the genes in our collection. Hybridization assays Rodríguez Martínez et al.
confirmed the PCR results, showing strong signals and bands co-migrating with chromosomal DNA for both oqxA and oqxB genes in all positive isolates tested by PCR. We also found simultaneous oqxA and oqxB signals in both chromosomal and large plasmid (.160 kb) locations in 16% (n¼ 18) and 13% (n¼ 15) of oqxA and oqxB genes, respectively (Table 1 and Figure 1 ). These assays confirmed that about 25% of repeatedly PCRnegative K. pneumoniae strains were also negative by Southern hybridization using oqxA and oqxB probes.
We selected four different K. pneumoniae clinical strains (4/07, 4/14, 39/63, 41/29) that showed strong signals of both oqxA and oqxB in plasmid DNA and carried out plasmid transfer assays. We did not find direct transfer of oqxAB, by either conjugation or electroporation, using E. coli as receptor (both J53 and DH10B genetic backgrounds). We did, however, obtain K. pneumoniae transformants harbouring a plasmid encoding OqxAB in all cases of K. pneumoniae ATCC 27799 being used as a receptor (confirmed by hybridization, data not shown) ( Table 2 ). This finding suggests that the oqxA -oqxB-hybridizing plasmids were non-conjugative, at least under our laboratory conditions. The MICs of fluoroquinolones increased 16-to 128-fold and the MIC of trimethoprim 16-to 32-fold, according to the substrate specificity previously described for this pump (Table 2) . 4 All these plasmids belonged to the IncF group, as has been previously described. 14 In this collection, 62.2% of strains were of intermediate susceptibility or resistant to ciprofloxacin and 9.6% and 24.5% harboured qnr (qnrA, qnrB or qnrS) genes or aac(6 ′ )Ib-cr, respectively, as previously reported.
9 -11 A summary of the characteristics of selected K. pneumoniae strains used in this study is provided in Table 1 . There was a correlation between the MICs of ciprofloxacin and the presence of plasmid-mediated quinolone resistance (PMQR) genes and QRDR substitutions. To determine whether the expression of oqxAB genes was associated with resistance to quinolones, we used RT-PCR to analyse the level of expression of chromosome-encoded oqxA in 24 selected K. pneumoniae clinical strains (these strains did not contain plasmid-located oqxAB genes; Figure 2a ). We divided this set of strains into ciprofloxacin-susceptible clinical strains (zone of inhibition around a 5 mg ciprofloxacin disc of more than 33 mm, MIC of Contribution of OqxAB to quinolone resistance in Klebsiella pneumoniae ciprofloxacin ≤0.06 mg/L, n¼ 8) and strains with reduced susceptibility to ciprofloxacin at least (zone of inhibition around a 5 mg ciprofloxacin disc was less than 30 mm, MIC of ciprofloxacin ≥0.125 mg/L, n¼ 16). This division was made on the basis that OqxAB efflux pumps themselves confer a low level of quinolone resistance. RT-PCR assays showed significantly higher oqxA expression (about 4-fold) in strains with reduced susceptibility to quinolones than in fully susceptible strains (Figure 2a , P ¼ 0.003). These data suggest that the level of expression of chromosomally encoded OqxAB could contribute to reduced susceptibility to quinolones in K. pneumoniae. No differences were found in the promoter regions of oqxA (TTGCAC 235 box, TACAAT 210 box and surrounding sequences) among K. pneumoniae ATCC 27799 and ATCC 700603 strains and various clinical isolates that differed in oqxA transcript levels (data not shown). In every case, these sequences were identical to those of K. pneumoniae MGH 78578 (GenBank accession number NC009648). Thus, the increased expression of oqxA in these strains does not appear to be due to mutations in the putative promoter and it may be that, as previously suggested, other undefined regulatory elements are implicated. 8 Recently it has been shown that global regulators such as ramA or rarA, belonging to the AraC-type transcriptional regulators family, and the local regulator oqxR, encoding a GntR-type regulator adjacent to the oqxAB operon, are implicated in up-regulation or down-regulation, respectively, of the expression of the oqxAB efflux pump. 21, 22 Additionally, although all strains containing plasmids coding for OqxAB were IS26 positive, no collinearity was found between this insertion sequence and oqxA in contrast to what is observed for pOLA52. 7 Interestingly, we observed that K. pneumoniae ATCC 700603 showed an 18-fold higher expression than K. pneumoniae ATCC 27799 (Figure 2b ). These two strains showed identical QRDR amino acid sequences for both GyrA and ParC as K. pneumoniae MGH 78578 (GenBank accession number NC009648) and the two OMPs OmpK35 and OmpK36 were also present in the two strains, as verified by SDS -PAGE (data not shown). We also found no PMQR genes in these reference strains. The data suggest that the observed differences in MIC of ciprofloxacin (0.25 and 0.03 mg/L for K. pneumoniae ATCC 700603 and K. pneumoniae ATCC 27799, respectively; Table 1 ) were in line with the differences in expression observed, supporting the role of these efflux pumps in terms of reduced susceptibility to quinolones in K. pneumoniae. We also observed that K. pneumoniae ATCC 700603 that overexpressed oqxA showed higher MICs of various disinfectants used in healthcare, such as sodium hypochlorite (2-fold), chlorhexidine digluconate (4-fold) or benzalkonium chloride (4-fold), in accordance with previous results. 4 Killing-curve assays showed a selective advantage for survival at 1 mg/L ciprofloxacin for K. pneumoniae ATCC 700603 that overexpressed the oqxA gene relative to K. pneumoniae ATCC 27799 (basal level of oqxA expression) (Figure 3 ). This ciprofloxacin concentration defines the borderline for establishing 12,23 Ciprofloxacin at 1 mg/L caused a marked reduction in the number of viable K. pneumoniae ATCC 27799 bacteria after 2 h of incubation. After 4 h, bacterial regrowth was noted. The marked reduction in viable bacteria was not observed for K. pneumoniae ATCC 700603, which overexpressed oqxA at 1 mg/L, supporting the potential impact of the OqxAB efflux pump on bacterial viability. No clear differences in bacterial viability were observed between the two strains at 1× MIC or 4× MIC (Figure 3) . Taken together, the findings support the idea that low-level quinolone resistance mechanisms such as the OqxAB system and PMQR 24, 25 could have an important impact in terms of fluoroquinolone activity.
In conclusion, the prevalence of the OqxAB efflux pump (both chromosomal and plasmidic) is high in ESBL-producing K. pneumoniae in Spain and represents a potential reservoir for the spread of oqxAB. High expression of this pump seems to contribute to the reduced susceptibility to quinolones in clinical isolates of K. pneumoniae.
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